Cargando…
Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus()
Anti-tumor necrosis factor-alpha induced lupus (ATIL) represents a major diagnostic and therapeutic challenge. Most cases of ATIL are caused by infliximab, followed by etanercept and adalimumab. Symptoms can range from common, mild cutaneous lesions to rare, serious pleural or pericardial effusions,...
Autores principales: | Almoallim, Hani, Al-Ghamdi, Yahya, Almaghrabi, Haneen, Alyasi, Omnia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504723/ https://www.ncbi.nlm.nih.gov/pubmed/23198006 http://dx.doi.org/10.2174/1874312901206010315 |
Ejemplares similares
-
The role of tumor necrosis factor-alpha in systemic lupus erythematosus
por: Aringer, Martin, et al.
Publicado: (2008) -
Transverse myelitis as a presenting feature of late onset systemic lupus erythematosus
por: Almoallim, Hani, et al.
Publicado: (2009) -
Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus
por: Postal, Mariana, et al.
Publicado: (2016) -
Mechanisms of Tumor Necrosis Factor-Alpha Inhibitor-Induced Systemic Lupus Erythematosus
por: Yen, Chung-Yang, et al.
Publicado: (2022) -
Familial Aggregation of High Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus
por: Mangale, Dorothy, et al.
Publicado: (2013)